Cerity Partners OCIO’s Medifast MED Stock Holding History

Cerity Partners OCIO’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$984K	Sell	8,527 -15,556	-65%	-$1.81M	0.03%	246
2022 Q3	$2.61M	Buy	24,083 +3,236	+16%	+$464K	0.09%	126
2022 Q2	$3.76M	Buy	20,847 +3,225	+18%	+$577K	0.12%	98
2022 Q1	$3.01M	Buy	17,622 +6,626	+60%	+$1.25M	0.09%	110
2021 Q4	$2.3M	Buy	10,996 +5,615	+104%	+$1.16M	0.07%	138
2021 Q3	$1.04M	Buy	5,381 +901	+20%	+$221K	0.03%	203
2021 Q2	$1.27M	Buy	+4,480	New	+$1.21M	0.04%	171
2021 Q1	–	Sell	-6,108	Closed	-$1.2M	–	389
2020 Q4	$1.2M	Sell	6,108 -105	-2%	-$18.6K	0.05%	153
2020 Q3	$1.02M	Sell	6,213 -207	-3%	-$34.1K	0.05%	157
2020 Q2	$891K	Buy	6,420 +49	+0.8%	+$4.5K	0.04%	166
2020 Q1	$398K	Buy	6,371 +723	+13%	+$65.8K	0.02%	225
2019 Q4	$568K	Buy	+5,648	New	+$547K	0.03%	216

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Cerity Partners OCIO's MED Position: Q4 2022 in Review

Cerity Partners OCIO reduced its Medifast (MED) stake by 65% in Q4 2022, selling an estimated $1.81M and leaving 8,527 shares worth $984K. The position accounts for 0.03% of the portfolio, ranked #246.

Cerity Partners OCIO first reported a position in MED in Q4 2019 and has held it in 12 quarters since. The position peaked at $3.76M in Q2 2022. 277 funds tracked by Wall St. Rank hold MED as of Q4 2022.

Cerity Partners OCIO held 8,527 shares of Medifast worth $984K as of Q4 2022.
Cerity Partners OCIO sold 15,556 Medifast shares in Q4 2022, an estimated $1.81M.
Medifast made up 0.03% of Cerity Partners OCIO's portfolio in Q4 2022, its #246 holding.
Cerity Partners OCIO first reported a position in Medifast in Q4 2019 and has held it in 12 quarters since.
Cerity Partners OCIO's Medifast position peaked at $3.76M in Q2 2022.
277 funds tracked by Wall St. Rank held Medifast as of Q4 2022.

Based on Cerity Partners OCIO's 13F filing for Q4 2022, filed 2 Feb 2023.